Inactive Instrument
Progenics Pharmaceuticals, Inc. Stock
Stocks
US7431871067
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
David Mims
CEO | Chief Executive Officer | 62 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/19/20 | Issuer sale | Director | 56,393 | 0.0651% | ||
| 6/19/20 | Issuer sale | Director | 170,000 | 0.1963% | ||
| 6/19/20 | Issuer sale | Executive/Senior Manager | 389,864 | 0.4502% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +1.49% | - | - | 355M | |
| -2.43% | -4.38% | +40.32% | +55.64% | 60.57B | |
| +1.49% | +4.95% | +22.41% | +99.46% | 55.51B | |
| +3.02% | +2.01% | +10.71% | +75.96% | 55.22B | |
| +1.61% | -3.30% | +22.77% | +33.16% | 43.27B | |
| -1.74% | -3.02% | +13.83% | +93.17% | 40.36B | |
| +3.22% | +4.30% | +227.37% | +776.49% | 41.63B | |
| -0.51% | -4.27% | +96.08% | +84.97% | 33.29B | |
| -1.09% | +0.69% | +14.20% | +45.26% | 32.27B | |
| -4.46% | +9.98% | -43.92% | +320.28% | 22.91B | |
| Average | -0.09% | +3.38% | +44.86% | +176.04% | 42.78B | |
| Weighted average by Cap. | +0.21% | +2.15% | +46.59% | +161.63% |
Employees
-
